Compumedics

Compumedics EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Compumedics (CMP.AX) as of Oct 17, 2026 is 3.16 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 1.31 % — a change of 140.39% (higher).

EBIT/Assets

3.16 %

YoY

140.39%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Compumedics is 2026 3.16 % . Operating Income to Assets Ratio (EBIT/Assets) of Compumedics was 2025 1.31 % . It decreases by 140.39% higher compared to the previous year.

The Compumedics EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2019
12.96 AUD
Jan 1, 2020
-2.13 AUD
Jan 1, 2021
2.87 AUD
Jan 1, 2022
1.29 AUD
Jan 1, 2023
-14.73 AUD
Jan 1, 2024
3.02 AUD
Jan 1, 2025
1.31 AUD
Jan 1, 2026
3.16 AUD
The Compumedics EBIT/Assets history
YEAREBIT/AssetsYoY
3.16 %+140.39%
1.31 %-56.54%
3.02 %-120.50%
-14.73 %-1,242.13%
1.29 %-55.05%
2.87 %-234.84%
-2.13 %-116.42%
12.96 %+46.28%
8.86 %+82.57%
4.85 %-60.53%
12.29 %-0.81%
12.39 %+52.82%
8.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Compumedics Stock analysis

What does Compumedics do? Compumedics Ltd., headquartered in Melbourne, Australia, operates in the Health Care sector, specializing in the research, development, manufacture, and distribution of medical equipment. The company employs 135 full-time staff and serves global markets across the Americas, Australia, Asia Pacific, and Europe and the Middle East. Its product portfolio includes sleep diagnostic systems, clinical EEG systems, brain monitoring solutions, ultrasonic blood-flow systems, and technical support services. Key offerings encompass Somfit/Somfit Pro, Grael 4K PSG:EEG, and Compumedics Neuroscan for neurology applications and brain research technologies. Compumedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compumedics stock

Operating Income to Assets Ratio (EBIT/Assets) of Compumedics is 3.16 % in 2026.

Operating Income to Assets Ratio (EBIT/Assets) of Compumedics changed from 1.31 % to 3.16 %, representing a 140.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Compumedics since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Compumedics with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Compumedics

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Compumedics